|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-9-17
|
|
pubmed:abstractText |
Instent restenosis remains a significant clinical problem. Identification of patients at risk for instent restenosis may allow selection of individualized appropriate therapeutic approaches. Genetic polymorphisms have been suggested to be associated with the risk of instent restenosis. Smoking is known to influence hemostatic parameters.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0160-9289
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
585-91
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11558839-Aged,
pubmed-meshheading:11558839-Coronary Disease,
pubmed-meshheading:11558839-Coronary Restenosis,
pubmed-meshheading:11558839-Female,
pubmed-meshheading:11558839-Follow-Up Studies,
pubmed-meshheading:11558839-Gene Frequency,
pubmed-meshheading:11558839-Genotype,
pubmed-meshheading:11558839-Humans,
pubmed-meshheading:11558839-Male,
pubmed-meshheading:11558839-Middle Aged,
pubmed-meshheading:11558839-Multivariate Analysis,
pubmed-meshheading:11558839-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:11558839-Polymorphism, Genetic,
pubmed-meshheading:11558839-Predictive Value of Tests,
pubmed-meshheading:11558839-Promoter Regions, Genetic,
pubmed-meshheading:11558839-Smoking,
pubmed-meshheading:11558839-Stents
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients.
|
|
pubmed:affiliation |
Medical Clinic I, University Hospital of Aachen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
